… Conclusion: There is limited but promising evidence that somatic mutations in thyroid cancer
can … a clinically useful tool based on cfDNA to improve the management of thyroid cancers. …

… TgAb interference with serum Tg measurements severely compromises the clinical utility of
Tg monitoring of DTC patients for recurrence (7, 32, 37–42). Current guidelines mandate that …

… review provides a catalogue of utility values for patients with thyroid cancer and at the same
… to make an informed choice about which utility values to include in an economic evaluation. …

… and early clinical studies, further research is needed to validate their clinical utility, establish
… Rigorous clinical trials and translational research efforts are required to determine the …

… thyroid adenoma (FTA). Considerable interest has been drawn to the potential clinical utility
… , among other molecular markers, for thyroid cancer [6]. Given these occurrence patterns in …

… The deep learning–based CAD system used in this study for CT diagnosis of cervical LNM
from thyroid cancer was clinically validated with an AUROC of 0.884. This approach may …

… that the clinical utility of Tg testing is enhanced by assay sensitivity, and that second generation
FS obviates the need for expensive recombinant human Thyroid Stimulating Hormone (…

Patients with differentiated thyroid carcinoma (DTC) are treated with 131 I therapy after total
thyroidectomy or surgical resection of recurrent tumor. However, some recurrent DTC lesions …

… concerning their expression profile and clinical utility during thyroid cancer (TC) progression
… target warranting further investigation for the treatment of more aggressive thyroid cancers. …

Background: The aim of this study was to evaluate post-therapy iodine-131 single-photon
emission computed tomography/computed tomography ( 131 I-SPECT/CT) imaging in …